Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-lipoic acid for diabetic optic neuropathy
ChiCTR2600126582Phase 4Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alpha-lipoic acid in Optic neuropathies (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Best corrected visual acuity and Visual field. Started Jun 2026; status: recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
Optic neuropathies
Beyond the preview
Go deeper on ChiCTR2600126582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126582.